Showing results (111-120 of 181) with videos related to
Sort By:
Pageof 19
Orphanet Journal of Rare Diseases|April 17, 2014
Clinical spectrum of females with HCCS mutation: from no clinical signs to a neonatal lethal form of the microphthalmia with linear skin defects (MLS) syndromeVanessa A van Rahden, Isabella Rau, Sigrid Fuchs, et al.Nature Communications|February 11, 2017
Epstein-Barr virus particles induce centrosome amplification and chromosomal instabilityAnatoliy Shumilov, Ming-Han Tsai, Yvonne T Schlosser, et al.Blood|February 12, 2011
Hyperdiploidy is less frequent in AL amyloidosis compared with monoclonal gammopathy of undetermined significance and inversely associated with translocation t(11;14)Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2008
Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patientsNiels Reinmuth, Anna Jauch, Elizabeth Chang Xu, et al.Cancers|September 28, 2023
Daratumumab, Bortezomib, and Dexamethasone for Treatment of Patients with Relapsed or Refractory Multiple Myeloma and Severe Renal Impairment: Results from the Phase 2 GMMG-DANTE TrialLisa B Leypoldt, Maria Gavriatopoulou, Britta Besemer, et al.The Journal of Pediatrics|June 12, 2012
Molecular karyotyping as a relevant diagnostic tool in children with growth retardation with Silver-Russell featuresSabrina Spengler, Matthias Begemann, Nadina Ortiz Brüchle, et al.International Journal of Cancer|March 21, 2008
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myelomaJens Hillengass, Christian M Zechmann, Andreas Nadler, et al.Blood|February 29, 2020
Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuriaChristoph R Kimmich, Tobias Terzer, Axel Benner, et al.Haematologica|May 20, 2017
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow upUte Hegenbart, Tilmann Bochtler, Axel Benner, et al.Leukemia|August 21, 2021
Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patientsSelcen Öztürk, Yashna Paul, Saira Afzal, et al.Pageof 19